Internationalization of Drug manufacturing and the Quality of Pharmaceutical products

Pidaparthi Praneeth

doi:https://doi.org/10.14445/23942576/IJPBE-V3I1P102

Research Article | Open Access

Volume 3 | Issue 1 | Year 2016 | Article Id. IJPBE-V3I1P102 | DOI : https://doi.org/10.14445/23942576/IJPBE-V3I1P102

Internationalization of Drug manufacturing and the Quality of Pharmaceutical products

Pidaparthi Praneeth

Citation :

Pidaparthi Praneeth, "Internationalization of Drug manufacturing and the Quality of Pharmaceutical products," International Journal of Pharmacy and Biomedical Engineering, vol. 3, no. 1, pp. 3-5, 2016. Crossref, https://doi.org/10.14445/23942576/IJPBE-V3I1P102

Abstract

The Internationalization of drug manufacture has increased day by day. As the production cost has increased, so the European countries and the rest of the world are shifting their manufacturing facilities to Asian countries like India, China etc. The Asian countries are playing a crucial role in drug manufacture (both API and Finished dosage forms). As the production increases, the quality of the product should also maintain the standards as per the regulatory requirements for human use. This article discusses the Internationalization of drug manufacture and challenges on the quality of pharmaceuticals.

Keywords

Internationalization, API, Finished dosage forms.

References

[1] Andre Jungmittag, Guido Reger, Thomas Reiss , "Changing Innovation in the Pharmaceutical Industry” Second edition (2012)
[2] Isotab fake medical crisis- 2012 from Wikipedia, the free encyclopaedia modified on 16 September 2015 available at https://en.wikipedia.org/wiki/2012_Pakistan_fake_medicine _crisis
[3] www.ich.org/products/guidelines/qualit y/article/qualityguidelines.html.
[4] Sachin C Itkar, Dr. Ns Vyawahare, “Drug Regulatory Affairs”, Third edition (2015).
[5] Joymalya Bhattacharya, “The Application of Lean Thinking To Pharmaceutical Quality System'' first edition May 2013.